Evidence map›Paper›PMID 32344839›Full record

ArticleMetabolites2020

Developmental Signatures of Microbiota-Derived Metabolites in the Mouse Brain.

Jonathan R Swann, Sonia O Spitzer, Rochellys Diaz Heijtz

Open access · goldAbstract read
In one paragraph

Article in Metabolites, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 3 countries.

Jonathan R SwannSchool of Human Development and Health, Faculty of Medicine, University of Southampton, University Road, Southampton SO17 1BJ, UK.
Sonia O SpitzerThe Francis Crick Institute, London, 1 Midland Rd, London NW1 1AT, UK.
Rochellys Diaz HeijtzDepartment of Neuroscience, Karolinska Institute, 171 77 Stockholm, Sweden.
Inserm · FRKarolinska Institutet · SEThe Francis Crick Institute · GB

Funding

Medical Research Council MR/N006321/1Swedish Research Council 521-2014-3883; 2018-06231
6 · The paper itself

Abstract

The gut microbiome is recognized to exert a wide-ranging influence on host health and disease, including brain development and behavior. Commensal bacteria can produce bioactive molecules that enter the circulation and impact host physiology and homeostasis. However, little is known about the potential for these metabolites to cross the blood-brain barrier and enter the developing brain under normal physiological conditions. In this study, we used a liquid chromatography-mass spectrometry-based metabolomic approach to characterize the developmental profiles of microbial-derived metabolites in the forebrains of mice across three key postnatal developmental stages, co-occurring with the maturation of the gut microbiota. We demonstrate that direct metabolites of the gut microbiome (e.g., imidazole propionate) or products of the combinatorial metabolism between the microbiome and host (e.g., 3-indoxyl-sulfate, trimethylamine-

Indexed as

developmentforebraingut–brain axishippurateimidazole propionateindolelactateindoxyl-sulfatemass spectrometrymetabolomemicrobiomemicrobiotaphenol-sulfatephenylacetylglutaminetrimethylamine-N-oxide

Identifiers

PMID32344839
PMCPMC7281085
OpenAlexW3020161996

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.